Histone acetylation in signal transduction by growth regulatory signals

Seminars in Cell and Developmental Biology

Volumn 10, Issue 2, 1999, Pages 197-203

  Magnaghi Jaulin, Laura ^b   Ait Si Ali, Slimane ^b   Harel Bellan, Annick ^a  

^a CNRS UPR 9079 Oncogenese Differenciation et Transduction du Signal   (France)

^b NONE

Author keywords

CBP; Chromatin; E2F; Histone acetylation; Rb

Indexed keywords

ACYLTRANSFERASE; CARRIER PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; GROWTH PROMOTOR; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; RETINOBLASTOMA BINDING PROTEIN 1; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F;

ACETYLATION; ANIMAL; BIOLOGICAL MODEL; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION; CHROMATIN; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HISTONES; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, RETINOIC ACID; RETINOBLASTOMA PROTEIN; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 0033109313     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.1999.0301     Document Type: Article

References (105)

1. Chambon P (1994) The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5:115-125
2. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454
3. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK et al (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
4. Wang H, Stillman DJ (1993) Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein. Mol Cell Biol 13:1805-1814
5. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48
6. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
7. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
8. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM (1996) Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103
9. Kraus WL, Kadonaga JT (1998) p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev 12:331-342
10. Aarnisalo P, Palvimo JJ, Janne OA (1998) CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci USA 95:2122-2127
11. Stein RW, Corrigan M, Yaciuk P, Whelan J, Moran E (1990) Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-in-ducing activity. J Virol 64:4421-4427
12. Arany Z, Sellers WR, Livingston DM, Eckner R (1994) E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators [letter]. Cell 77:799-800
13. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH (1993) Phorphorylated CREB binds specifically to the nuclear protein CBP. Nature 265:855-859
14. Janknecht R, Hunter T (1996) Versatile molecular glue. Transcriptional control. Curr Biol 6:951-954
15. Puri PL, Avantaggiati ML, Balsano C, Sang N, Graessmann A, Giordano A, Levrero M (1997) p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J 16:369-383
16. Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko W, Howard BH, Kedes L, Wang JYJ, Graessmann A, Nakatani Y, Levrero M (1997) Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1:35-45
17. Buckingham M (1994) Muscle differentiation. Which myogenic factors make muscle? Curr Biol 4:61-63
18. Yang XJ, Ogryzko W, Nishikawa J, Howard BH, Nakatani Y (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324
19. Blanco JCG, Minucci S, Lu JM, Yang XJ, Walker KK, Chen HW, Evans RM, Nakatani Y, Ozato K (1998) The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 12:1638-1651
20. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen TM, Glass CK, Rosenfeld MG (1998) Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703-707
21. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O'Malley BW (1997) Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci USA 94:7879-7884
22. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198
23. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580
24. Bravo R, Burckhardt J, Curran T, MÅller R (1985) Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J 4:1193-1197
25. Blackwood EM, Luscher B, Kretzner L, Eisenman RN (1991) The Myc:Max protein complex and cell growth regulation. Cold Spring Harb Symp Quant Biol 56:109-117
26. Amati B, Land H (1994) Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 4:102-108
27. Bouchard C, Staller P, Eilers M (1998) Control of cell proliferation by Myc. Trends Cell Biol 8:202-206
28. Ayer DE, Lawrence QA, Eisenman RN (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast represser Sin3. Cell 80:767-776
29. Pazin MJ, Kadonaga JT (1997) What's up and down with histone deacetylation and transcription? Cell 89:325-328
30. Alland L, Muhle R, Hou HJr, PotesJ, Chin L, Schreiber-Agus N, DePinho RA (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55
31. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-347
32. Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D (1997) Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89:357-364
33. Zhang Y, Sun ZW, Iratni R, Erdjumentbromage H, Tempst P, Hampsey M, Reinberg D (1998) SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol Cell 1:1021-1031
34. Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356
35. Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, Luscher B (1997) Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 7:357-365
36. Nevins JR, Leone G, Degregori J, Jakoi L (1997) Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 173:233-236
37. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262
38. Helin K (1998) Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8:28-35
39. Weinberg RA (1992) The retinoblastoma gene and gene product. Cancer Surv 12:43-57
40. Trouche D (1997) [Control of cell proliferation by the retinoblastoma gene product (editorial)]. Pathol Biol (Paris) 45:5-8
41. Mulligan G, Jacks T (1998) The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 14:223-229
42. Hu QJ, Bautista C, Edwards GM, Defeo-Jones D, Jones RE, Harlow E (1991) Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol 11:5792-5799
43. Ewen ME, Xing YG, Lawrence JB, Livingston DM (1991) Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164
44. Li Y, Graham C, Lacy S, Duncan AM, Whyte P (1993) The adenovirus E1A-associated 130-kDa protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377
45. Hannon GJ, Demetrick D, Beach D (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391
46. Taya Y (1997) RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci 22:14-17
47. Dyson N, Buchkovich K, Whyte P, Harlow E (1989) Cellular proteins that are targetted by DNA tumor viruses for transformation. Princess Takamatsu Symp 20:191-198
48. Hoppe-Seyler F, Butz K (1995) Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. J Mol Med 73:529-538
49. Moran E (1993) Interaction of adenoviral proteins with pRB and p53. FASEB J 7:880-885
50. Ludlow JW, Shon J, Pipas JM, Livingston DM, DeCaprio JA (1990) The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387-396
51. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006
52. Goodrich DW, Wang NP, Qian YW, Lee EYHP, Lee WH (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302
53. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A (1992) A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350
54. Helin K, Harlow E, Fattaey A (1993) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13:6501-6508
55. Nevins JR, DeGregori J, Jakoi L, Leone G (1997) Functional analysis of E2F transcription factor. Methods Enzymol 283:205-219
56. Nevins JR (1998) Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 9:585-593
57. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061
58. Flemington EK, Speck SH, Kaelin WG Jr (1993) E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 90:6914-6918
59. Gu WG, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324
60. Planassilva MD, Weinberg RA (1997) The restriction point and control of cell proliferation. Curr Opin Cell Biol 9:768-772
61. Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761
62. Hatakeyama M, Brill JA, Fink GR, Weinberg RA (1994) Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev 8:1759-1771
63. DeGregori J, Kowalik T, Nevins JR (1995) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes [published erratum appears in Mol Cell Biol 1995 Oct;15(10):5846-5847]. Mol Cell Biol 15:4215-4224
64. Hateboer G, Wobst A, Petersen BO, Le Cam L, Vigo E, Sardet C, Helin K (1998) Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol 18:6679-6697
65. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR, Williams RS (1998) Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 95:3603-3608
66. Weinberg RA (1996) E2F and cell proliferation: a world turned upside down. Cell 85:457-459
67. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-548
68. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG Jr, Livingston DM, Orkin SH, Greenberg ME (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-561
69. Krek W, Xu G, Livingston DM (1995) Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158
70. Weintraub SJ, Prater CA, Dean DC (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261
71. Bremner R, Cohen BL, Sopta M, Hamel PA, Ingles CJ, Gallie BL, Phillips RA (1995) Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol Cell Biol 1555:3256-3265
72. Zacksenhaus E, Jiang Z, Phillips RA, Gallie BL (1996) Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. EMBO J 15:5917-5927
73. Chow KN, Starostik P, Dean DC (1996) The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol Cell Biol 16:7173-7181
74. Chow KN, Dean DC (1996) Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol 16:4862-4868
75. Starostik P, Chow KN, Dean DC (1996) Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol 16:3606-3614
76. Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC (1995) Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815
77. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601
78. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605
79. Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473
80. Kaelin WG Jr, Ewen ME, Livingston DM (1990) Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol Cell Biol 10:3761-3769
81. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D (1998) The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc Natl Acad Sci USA 95:10493-10498
82. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL (1996) pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 10:3051-3064
83. Singh P, Coe J, Hong W (1995) A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374:562-565
84. Chen PL, Riley DJ, Chen Y, Lee WH (1996) Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 10:2794-2804
85. -/- muscle cells. Science 264:1467-1470
86. Novitch BG, Mulligan GJ, Jacks T, Lassar AB (1996) Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J Cell Biol 135:441-456
87. Kiess M, Gill RM, Hamel PA (1995) Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ 6:1287-1298
88. Raschella G, Tanno B, Bonetto F, Amendola R, Battista T, De Luca A, Giordano A, Paggi MG (1997) Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation. J Cell Biochem 67:297-303
89. Richon VM, Lyle RE, McGehee RE Jr (1997) Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J Biol Chem 272:10117-10124
90. Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA (1996) Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit Rev Biochem Mol Biol 31:237-271
91. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WG (1998) Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12:95-106
92. Johnston LA, Tapscott SJ, Eisen H (1992) Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin. Mol Cell Biol 12:5123-5130
93. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331
94. Prives C (1993) Doing the right thing: feedback control and p53. Curr Opin Cell Biol 5:214-218
95. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347
96. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
97. Fuchs SY, Fried VA, Ronai Z (1998) Stress-activated kinases regulate protein stability [In Process Citation]. Oncogene 17:1483-1490
98. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12:2831-2841
99. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606
100. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827
101. Gu W, Shi XL, Roeder RG (1997) Synergistic activation of transcription by CBP and p53. Nature 387:819-823
102. Chawla S, Hardingham GE, Quinn DR, Bading H (1998) CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science 281:1505-1509
103. Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommun B, Trouche D, Harel-Bellan A (1998) CBP histone acetyl-transferase activity is controlled by cycle-dependent kinases and E1A. Nature, in press
104. Trouche D, Cook A, Kouzarides T (1996) The CBP coactivator stimulates E2F1/DP1 activity. Nucleic Acids Res 24:4139-4145
105. Trouche D, Kouzarides T (1996) E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc Natl Acad Sci USA 93:1439-1442